Eliasson, E.
470  Ergebnisse:
Personensuche X
?
 
?
2

Standard dosing of piperacillin and meropenem fail to achie..:

Petersson, J. ; Giske, C. G. ; Eliasson, E.
Acta Anaesthesiologica Scandinavica.  60 (2016)  10 - p. 1425-1436 , 2016
 
?
5

UGT1A4*3 Encodes Significantly Increased Glucuronidation of..:

Haslemo, T ; Loryan, I ; Ueda, N...
Clinical Pharmacology & Therapeutics.  92 (2012)  2 - p. 221-227 , 2012
 
?
6

Clinically Significant CYP2C Inhibition by Noscapine but No..:

Rosenborg, S ; Stenberg, M ; Otto, S...
Clinical Pharmacology & Therapeutics.  88 (2010)  3 - p. 343-346 , 2010
 
?
7

Drug–drug interactions that reduce the formation of pharmac..:

Mannheimer, B. ; Eliasson, E.
Journal of Internal Medicine.  268 (2010)  6 - p. 540-548 , 2010
 
?
8

The Convergence of Conventional Therapeutic Drug Monitoring..:

Sjöqvist, F ; Eliasson, E
Clinical Pharmacology & Therapeutics.  81 (2007)  6 - p. 899-902 , 2007
 
?
9

Accumulation of celecoxib with a 7-fold higher drug exposur..:

LUNDBLAD, M ; OHLSSON, S ; JOHANSSON, P..
Clinical Pharmacology & Therapeutics.  79 (2006)  3 - p. 287-288 , 2006
 
?
10

Reply:

ELIASSON, E ; LUNDBLAD, M
Clinical Pharmacology & Therapeutics.  80 (2006)  3 - p. 301-302 , 2006
 
?
 
?
12

Substrate-regulated, cAMP-dependent phosphorylation, denatu..:

Eliasson, E. ; Mkrtchian, S. ; Halpert, J.R..
Journal of Biological Chemistry.  269 (1994)  28 - p. 18378-18383 , 1994
 
?
13

Hormone- and substrate-regulated intracellular degradation ..:

Eliasson, E ; Mkrtchian, S ; Ingelman-Sundberg, M
Journal of Biological Chemistry.  267 (1992)  22 - p. 15765-15769 , 1992
 
?
14

Substrate-, hormone-, and cAMP-regulated cytochrome P450 de..:

Eliasson, E ; Johansson, I ; Ingelman-Sundberg, M
Proceedings of the National Academy of Sciences.  87 (1990)  8 - p. 3225-3229 , 1990
 
?
 
1-15
Mehr Literatur finden